Southport Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Southport Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-9,000	Closed	-$804K	–	41
2023 Q4	$804K	Buy	+9,000	New	+$668K	3.47%	10
2023 Q1	–	Sell	-6,500	Closed	-$540K	–	27
2022 Q4	$540K	Buy	+6,500	New	+$526K	2.87%	15
2022 Q3	–	Sell	-5,000	Closed	-$371K	–	30
2022 Q2	$371K	Buy	+5,000	New	+$375K	1.58%	19

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Southport Management's XBI Position: Q1 2024 in Review

Southport Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2024, closing a stake of 9,000 shares — an estimated $804K sold.

Southport Management first reported a position in XBI in Q2 2022 and held it in 3 quarters. The position peaked at $804K in Q4 2023. 780 funds tracked by Wall St. Rank hold XBI as of Q1 2024.

Southport Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2024 after selling out during the quarter.
Southport Management sold 9,000 State Street SPDR S&P Biotech ETF shares in Q1 2024, an estimated $804K.
Southport Management first reported a position in State Street SPDR S&P Biotech ETF in Q2 2022 and held it in 3 quarters.
Southport Management's State Street SPDR S&P Biotech ETF position peaked at $804K in Q4 2023.
780 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2024.

Based on Southport Management's 13F filing for Q1 2024, filed 15 May 2024.